Meet Matchstick.

We invent, test, refine, and commercialize better solutions for chronic disease, specialty pharmaceuticals, combination products, and digital health.

We’re trusted by the world’s largest pharmaceutical and medical device companies. We crack problems that defy easy elevator speeches and cookie-cutter approaches.

Image

We find hidden differentiation.

Image
Image

We find hidden differentiation.

Many can do market or user research; few can separate the signal from the static. Our clinical, technical, and commercial experience helps us identify unmet needs and hidden leverage points others miss.

The result is actionable, specific opportunities for new physical products and digital services that can truly differentiate.

how we uncover opportunity

We invent and refine new products and services.

Image
Image

We invent and refine new products and services.

Anyone can have a new idea; few can create relevant, useful concepts. Our approaches for innovation and refinement are used across pharma.

The result is novel, often patentable ideas that build a lead in the market, protect competitive advantage, and improve patient experience.

how we approach innovation

We build the strategy and investment case.

Image
Image

We build the strategy and investment case.

Without a solid plan, new ideas stall quickly. Our corporate experience has taught us to validate assumptions, anticipate objections, and understand all the stakeholders.

The result is a clear strategy, internal confidence, funding to succeed, and urgency to start.

How we make the case

The Matchstick story, in brief.

Since 2009, we’ve been an intentionally small, tightly held, highly independent team of engineers, clinicians, and researchers. Creativity, deep knowledge, and intense ownership are our secret sauce.

  • 2009

    Marty & Erika led established and growing businesses of all sizes, at every stage of growth cycle, often in price-sensitive, highly competitive environments. Multi-functional teams were the norm, and senior leadership meetings were a constant. We made extensive use of consultants.

    Here, the idea was hatched. Start the consulting company we wished for but couldn't find. We left corporate, intent on doing things differently.

  • 2014

    We met Chris, who had extensive clinical trial research experience. He had a vision for the role of front-line clinicians in our work. Pharmacists’ experience dispensing, preparing, and counseling patients on medications was crucial, but missing from the discussion.

    Our clients quickly saw the value of clinical expertise around medication delivery, health outcomes measurement, digital health, and medication errors. With the value well established, he became a Principal and our Clinical Leader. He then started the first post-PharmD Industry Fellowship in combination products, a selective and rigorous two-year program that formalizes this clinical expertise.

  • Today

    Word of mouth built a company, focused on market-leading work on chronic disease and treatment. Speaking clinical, technical, and commercial fluently, clients often told us how to evolve next. We’ve simply listened and responded – moving from combination products into high-value orals and inhalation, then to connected devices, mobile medical apps (MMAs), digital health and digital biomarkers, patient initiation and training, instructional content, and patient support program components.

    Hard work has built an impressive track record studied by much larger firms. We’ve established a unique culture, built an award winning program for talent management, published and presented our work, and continue to have larger and larger impact.

  • Are you a Good Match? Want to be part of our next chapter or learn more?